The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Abstract
Purpose: Molecular testing of colorectal cancers (CRCs) to improve patient care and outcomes of targeted and conventional therapies has been the center of many recent studies, including clinical trials. Evidence-based recommendations for the molecular testing of CRC tissues to guide epidermal growth factor receptor (EGFR) –targeted therapies and conventional chemotherapy regimens are warranted in clinical practice. The purpose of this guideline is to develop evidence-based recommendations to help establish standard molecular biomarker testing for CRC through a systematic review of the literature. Methods: The American Society for Clinical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO) convened an Expert Panel to develop an evidence-based guideline to help establish standard molecular biomarker testing, guide targeted therapies, and advance personalized care for patients with CRC. A comprehensive literature search that included over 4,000 articles was conducted to gather data to inform this guideline. Results: Twenty-one guideline statements (eight recommendations, 10 expert consensus opinions and three no recommendations) were established. Recommendations: Evidence supports mutational testing for genes in the EGFR signaling pathway, since they provide clinically actionable information as negative predictors of benefit to anti-EGFR monoclonal antibody therapies for targeted therapy of CRC. Mutations in several of the biomarkers have clear prognostic value. Laboratory approaches to operationalize molecular testing for predictive and prognostic molecular biomarkers involve selection of assays, type of specimens to be tested, timing of ordering of tests and turnaround time for testing results. Additional information is available at: www.asco.org/CRC-markers-guideline and www.asco.org/guidelineswiki
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
Self-citationGRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer
Fishel, R., Lescoe, M. K., Rao, M. R. S., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., & Kolodner, R. (1993) · Cell · doi:10.1016/0092-8674(93)90546-3 · Cited by 2,873
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263
Liquid Biopsies: Genotyping Circulating Tumor DNA
Diaz, L. A., & Bardelli, A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2011 · Cited by 2,210
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Self-citationDe Roock, W., Claes, B., Bernasconi, D., De Schutter, J., Biesmans, B., Fountzilas, G., Kalogeras, K. T., Kotoula, V., Papamichael, D., Laurent-Puig, P., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70130-3 · Cited by 2,144
Bronner, C. E., Baker, S. M., Morrison, P. T., Warren, G., Smith, L. G., Lescoe, M. K., Kane, M., Earabino, C., Lipford, J., Lindblom, A., et al. (1994) · Nature · doi:10.1038/368258a0 · Cited by 2,052
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156
Self-citationCremolini, C., Loupakis, F., Antoniotti, C., Lupi, C., Sensi, E., Lonardi, S., Mezi, S., Tomasello, G., Ronzoni, M., Zaniboni, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00122-9 · Cited by 1,092
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
Liao, X., Lochhead, P., Nishihara, R., Morikawa, T., Kuchiba, A., Yamauchi, M., Imamura, Y., Qian, Z. R., Baba, Y., Shima, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1207756 · Cited by 843
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability
Liu, B., Nicolaides, N. C., Markowitz, S., Willson, J. K. V., Parsons, R. E., Jen, J., Papadopolous, N., Peltomäki, P., de la Chapelle, A., Hamilton, S. R., et al. (1995) · Nature Genetics · doi:10.1038/ng0195-48 · Cited by 802
Self-citationProphylactic Surgery to Reduce the Risk of Gynecologic Cancers in the Lynch Syndrome
Schmeler, K. M., Lynch, H. T., Chen, L.-M., Munsell, M. F., Soliman, P. T., Clark, M. B., Daniels, M. S., White, K. G., Boyd-Rogers, S. G., Conrad, P. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052627 · Cited by 794
Van Cutsem, E., Lenz, H.-J., Köhne, C.-H., Heinemann, V., Tejpar, S., Melezínek, I., Beier, F., Stroh, C., Rougier, P., van Krieken, J. H., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4812 · Cited by 789
De Roock, W., Jonker, D. J., Di Nicolantonio, F., Sartore-Bianchi, A., Tu, D., Siena, S., Lamba, S., Arena, S., Frattini, M., Piessevaux, H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1535 · Cited by 748
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
Linardou, H., Dahabreh, I. J., Kanaloupiti, D., Siannis, F., Bafaloukos, D., Kosmidis, P., Papadimitriou, C. A., & Murray, S. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70206-7 · Cited by 739
Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2466 · Cited by 739
Laurent-Puig, P., Cayre, A., Manceau, G., Buc, E., Bachet, J.-B., Lecomte, T., Rougier, P., Lievre, A., Landi, B., Boige, V., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6796 · Cited by 673
Biagi, J. J., Raphael, M. J., Mackillop, W. J., Kong, W., King, W. D., & Booth, C. M. (2011) · JAMA · doi:10.1001/jama.2011.749 · Cited by 632
Roock, W. D., Vriendt, V. D., Normanno, N., Ciardiello, F., & Tejpar, S. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70209-6 · Cited by 603
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
Frattini, M., Saletti, P., Romagnani, E., Martin, V, Molinari, F., Ghisletta, M., Camponovo, A., Etienne, L. L., Cavalli, F., & Mazzucchelli, L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6604009 · Cited by 540
Sorich, M. J., Wiese, M. D., Rowland, A., Kichenadasse, G., McKinnon, R. A., & Karapetis, C. S. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu378 · Cited by 540
Pietrantonio, F., Petrelli, F., Coinu, A., Di Bartolomeo, M., Borgonovo, K., Maggi, C., Cabiddu, M., Iacovelli, R., Bossi, I., Lonati, V., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.054 · Cited by 486
Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
Lochhead, P., Kuchiba, A., Imamura, Y., Liao, X., Yamauchi, M., Nishihara, R., Qian, Z. R., Morikawa, T., Shen, J., Meyerhardt, J. A., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt173 · Cited by 442
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
(2015) · New England Journal of Medicine · doi:10.1056/nejmc1510353 · Cited by 426
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0720-oa · Cited by 426
Perrone, F., Lampis, A., Orsenigo, M., Di Bartolomeo, M., Gevorgyan, A., Losa, M., Frattini, M., Riva, C., Andreola, S., Bajetta, E., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn541 · Cited by 410
Guastadisegni, C., Colafranceschi, M., Ottini, L., & Dogliotti, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.009 · Cited by 380
Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., Chan, A. T., Engelman, J. A., Kraft, P., Cantley, L. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6544 · Cited by 323
A Large Cohort Study of Long-Term Daily Use of Adult-Strength Aspirin and Cancer Incidence
Jacobs, E. J., Thun, M. J., Bain, E. B., Rodriguez, C., Henley, S. J., & Calle, E. E. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk132 · Cited by 322
Gavin, P. G., Colangelo, L. H., Fumagalli, D., Tanaka, N., Remillard, M. Y., Yothers, G., Kim, C., Taniyama, Y., Kim, S. I., Choi, H. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0605 · Cited by 320
Rowland, A., Dias, M. M., Wiese, M. D., Kichenadasse, G., McKinnon, R. A., Karapetis, C. S., & Sorich, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.173 · Cited by 319
Parsons, M. T., Buchanan, D. D., Thompson, B., Young, J. P., & Spurdle, A. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100714 · Cited by 311
Des Guetz, G., Schischmanoff, O., Nicolas, P., Perret, G.-Y., Morere, J.-F., & Uzzan, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.018 · Cited by 291
Comparative Genomic Analysis of Primary Versus Metastatic Colorectal Carcinomas
Vakiani, E., Janakiraman, M., Shen, R., Sinha, R., Zeng, Z., Shia, J., Cercek, A., Kemeny, N., D'Angelica, M., Viale, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.2994 · Cited by 282
Fitzgibbons, P. L., Bradley, L. A., Fatheree, L. A., Alsabeh, R., Fulton, R. S., Goldsmith, J. D., Haas, T. S., Karabakhtsian, R. G., Loykasek, P. A., Marolt, M. J., et al. (2014) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2013-0610-cp · Cited by 280
Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Liao, X., Morikawa, T., Lochhead, P., Imamura, Y., Kuchiba, A., Yamauchi, M., Nosho, K., Qian, Z. R., Nishihara, R., Meyerhardt, J. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2410 · Cited by 258
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology
Febbo, P. G., Ladanyi, M., Aldape, K. D., De Marzo, A. M., Hammond, M. E., Hayes, D. F., Iafrate, A. J., Kelley, R. K., Marcucci, G., Ogino, S., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0137 · Cited by 255
Aspirin Dose and Duration of Use and Risk of Colorectal Cancer in Men
Chan, A. T., Giovannucci, E. L., Meyerhardt, J. A., Schernhammer, E. S., Wu, K., & Fuchs, C. S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.035 · Cited by 242
Domingo, E., Church, D. N., Sieber, O., Ramamoorthy, R., Yanagisawa, Y., Johnstone, E., Davidson, B., Kerr, D. J., Tomlinson, I. P. M., & Midgley, R. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.0322 · Cited by 210
Tol, J., Dijkstra, J. R., Klomp, M., Teerenstra, S., Dommerholt, M., Vink-Börger, M. E., van Cleef, P. H., van Krieken, J. H., Punt, C. J. A., & Nagtegaal, I. D. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.036 · Cited by 210
Rubenstein, J. H., Enns, R., Heidelbaugh, J., Barkun, A., Adams, M. A., Dorn, S. D., Dudley-Brown, S. L., Flamm, S. L., Gellad, Z. F., Gruss, C. B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.07.036 · Cited by 204
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M., Cubiella, J., Balaguer, F., Sempere, L., Xicola, R. M., Bujanda, L., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.016 · Cited by 197
Relevance, Pathogenesis, and Testing Algorithm for Mismatch Repair–Defective Colorectal Carcinomas
Funkhouser, W. K., Lubin, I. M., Monzon, F. A., Zehnbauer, B. A., Evans, J. P., Ogino, S., & Nowak, J. A. (2012) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2011.11.001 · Cited by 189
Self-citationMao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
Cottrell, C. E., Al-Kateb, H., Bredemeyer, A. J., Duncavage, E. J., Spencer, D. H., Abel, H. J., Lockwood, C. M., Hagemann, I. S., O’Guin, S. M., Burcea, L. C., et al. (2014) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2013.10.002 · Cited by 184
Taïeb, J., Zaanan, A., Malicot, K. L., Julié, C., Blons, H., Mineur, L., Bennouna, J., Tabernero, J. M., Mini, E., Folprecht, G., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5225 · Cited by 182
Standard Mutation Nomenclature in Molecular Diagnostics
Ogino, S., Gulley, M. L., den Dunnen, J. T., & Wilson, R. B. (2007) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2007.060081 · Cited by 172
Dahabreh, I. J., Terasawa, T., Castaldi, P. J., & Trikalinos, T. A. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-1-201101040-00006 · Cited by 172
The prognostic role of KRAS, BRAF, PIK3CA and PTEN in colorectal cancer
Eklöf, V, Wikberg, M. L., Edin, S., Dahlin, A. M., Jonsson, B.-A., Öberg, Å., Rutegård, J., & Palmqvist, R. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.212 · Cited by 164
Karapetis, C. S., Jonker, D., Daneshmand, M., Hanson, J. E., O'Callaghan, C. J., Marginean, C., Zalcberg, J. R., Simes, J., Moore, M. J., Tebbutt, N. C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0606 · Cited by 159
PTEN mutations are common in sporadic microsatellite stable colorectal cancer
Nassif, N. T., Lobo, G. P., Wu, X., Henderson, C. J., Morrison, C. D., Eng, C., Jalaludin, B. B., & Segelov, E. (2004) · Oncogene · doi:10.1038/sj.onc.1207059 · Cited by 158
Microsatellite Instability and Colorectal Cancer
Geiersbach, K. B., & Samowitz, W. S. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0035-ra · Cited by 153
Cicek, M. S., Lindor, N. M., Gallinger, S., Bapat, B. V., Hopper, J. L., Jenkins, M. A., Young, J. P., Buchanan, D. D., Walsh, M. D., Marchand, L. L., et al. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.12.004 · Cited by 148
Self-citationBRAF Mutation in Colorectal Cancer: An Update: Supplementary Issue: Biomarkers for Colon Cancer
Barras, D. (2015) · Biomarkers in Cancer · doi:10.4137/bic.s25248 · Cited by 138
Berg, M., Danielsen, S. A., Ahlquist, T. C., Merok, M. A., Ågesen, T. H., Vatn, M. H., Mala, T., Sjo, O. H., Bakka, A. O., Moberg, I. O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013978 · Cited by 137
Sawai, H., Yasuda, A., Ochi, N., Ma, J., Matsuo, Y., Wakasugi, T., Takahashi, H., Funahashi, H., Sato, M., & Takeyama, H. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-56 · Cited by 135
Yuan, Z., Wang, X.-Y., Qin, Q., Chen, D., Zhong, Q., Wang, L., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065995 · Cited by 128
Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
Temraz, S., Mukherji, D., & Shamseddine, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160922976 · Cited by 117
Vale, C. L., Tierney, J. F., Fisher, D. J., Adams, R., Kaplan, R. S., Maughan, T., Parmar, M., & Meade, A. M. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.002 · Cited by 115
Franklin, W. A., Haney, J., Sugita, M., Bemis, L., Jimeno, A., & Messersmith, W. A. (2009) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2010.080131 · Cited by 111
Viray, H., Li, K., Long, T. A., Vasalos, P., Bridge, J. A., Jennings, L. J., Halling, K. C., Hameed, M., & Rimm, D. L. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0561-cp · Cited by 110
Mao, C., Huang, Y., Yang, Z., Zheng, D., Chen, J., & Tang, J. (2012) · Cancer · doi:10.1002/cncr.27804 · Cited by 107
Lang, A. H., Drexel, H., Geller-Rhomberg, S., Stark, N., Winder, T., Geiger, K. D., & Muendlein, A. (2011) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.007 · Cited by 107
Çolakoğlu, T., Yıldırım, S., Kayaselçuk, F., Nursal, T. Z., Ezer, A., Noyan, T., Karakayalı, H., & Haberal, M. A. (2008) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2007.05.061 · Cited by 106
Qiu, L., Mao, C., Zhang, J., Zhu, X.-D., Liao, R.-Y., Xue, K., Li, J., & Chen, Q. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.05.022 · Cited by 105
Sukhai, M. A., Craddock, K. J., Thomas, M., Hansen, A. R., Zhang, T., Siu, L. L., Bedard, P. L., Stockley, T. L., & Kamel‐Reid, S. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.47 · Cited by 101
Mao, C., Liao, R.-Y., Qiu, L., Wang, X.-W., Ding, H., & Chen, Q. (2010) · Molecular Biology Reports · doi:10.1007/s11033-010-0351-4 · Cited by 99
Tol, J., Dijkstra, J. R., Vink-Börger, M. E., Nagtegaal, I. D., Punt, C. J. A., van Krieken, J. H., & Ligtenberg, M. J. L. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00788.x · Cited by 91
Baas, J. M., Krens, L. L., Guchelaar, H.-J., Morreau, H., & Gelderblom, H. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0024 · Cited by 89
Hoyle, M., Crathorne, L., Peters, J., Jones-Hughes, T., Cooper, C., Napier, M., Tappenden, P., & Hyde, C. (2013) · Health Technology Assessment · doi:10.3310/hta17140 · Cited by 85
Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysis
Petrelli, F., Borgonovo, K., Cabiddu, M., Ghilardi, M., & Barni, S. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1149-0 · Cited by 85
Hatch, S. B., Lightfoot, H. M., Garwacki, C. P., Moore, D. T., Calvo, B. F., Woosley, J. T., Sciarrotta, J., Funkhouser, W. K., & Farber, R. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0234 · Cited by 85
Self-citationPTEN status in advanced colorectal cancer treated with cetuximab
Negri, F. V., Bozzetti, C., Lagrasta, C. A., Crafa, P., Bonasoni, M. P., Camisa, R., Pedrazzi, G., & Ardizzoni, A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605471 · Cited by 83
Yang, Z., Wu, X., Huang, Y., Di, M., Zheng, D., Chen, J., Ding, H., Mao, C., & Tang, J.-L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28153 · Cited by 82
Sundström, M., Edlund, K., Lindell, M., Glimelius, B. L. G., Birgisson, H., Micke, P., & Botling, J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-660 · Cited by 81
Adelstein, B., Dobbins, T., Harris, C. A., Marschner, I. C., & Ward, R. L. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.031 · Cited by 75
Implications of mismatch repair-deficient status on management of early stage colorectal cancer.
Kawakami, H., Zaanan, A., & Sinicrope, F. A. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.065 · Cited by 72
Wong, N. A. C. S., de Castro, D. G., Salto‐Tellez, M., Butler, R., Díaz‐Cano, S. J., Ilyas, M., Newman, W. G., Shaw, E. C., Tanière, P., & Walsh, S. V. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202467 · Cited by 70
Jiang, Z., Li, C., Li, F., & Wang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056205 · Cited by 68
Next‐generation sequencing: a change of paradigm in molecular diagnostic validation
Salto‐Tellez, M., & de Castro, D. G. (2014) · The Journal of Pathology · doi:10.1002/path.4365 · Cited by 67
Ren, J., Li, G., Ge, J., Li, X., & Zhao, Y. (2012) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e318251d8d9 · Cited by 67
Evaluation of EGFR mutation status in cytology specimens: An institutional experience
Aisner, D. L., Deshpande, C. G., Baloch, Z. W., Watt, C. D., Litzky, L. A., Malhotra, B., Sepulveda, A. R., Langer, C. J., Evans, T. L., & Deerlin, V. M. V. (2011) · Diagnostic Cytopathology · doi:10.1002/dc.21851 · Cited by 66
Self-citationGologan, A., & Sepulveda, A. R. (2005) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2004.12.001 · Cited by 62
Self-citationmetastases, A.-E. A. F. L., Petrelli, F., & Barni, S. (2012) · International Journal of Colorectal Disease · doi:10.1007/s00384-012-1438-2 · Cited by 61
Test Verification and Validation for Molecular Diagnostic Assays
Halling, K. C., Schrijver, I., & Persons, D. L. (2011) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0212-ed · Cited by 57
Petrelli, F., Coinu, A., Cabiddu, M., Ghilardi, M., & Barni, S. (2013) · Medical Oncology · doi:10.1007/s12032-013-0650-4 · Cited by 56
Xu, Q., Xu, A. T., Zhu, M., Tong, J. L., Xi Tao, X. U., & Ran, Z. H. (2013) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12063 · Cited by 55
Methods-Based Proficiency Testing in Molecular Genetic Pathology
Schrijver, I., Aziz, N., Jennings, L. J., Richards, C. S., Voelkerding, K. V., & Weck, K. E. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.02.002 · Cited by 55
Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
Ogino, S., Liao, X., Imamura, Y., Yamauchi, M., McCleary, N. J., Ng, K., Niedzwiecki, D., Saltz, L. B., Mayer, R. J., Whittom, R., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt298 · Cited by 54
Bando, H., Yoshino, T., Shinozaki, E., Nishina, T., Yamazaki, K., Yamaguchi, K., Yuki, S., Kajiura, S., Fujii, S., Yamanaka, T., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-405 · Cited by 53
Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis
Ma, E. S. K., Wong, C., Law, F. B. F., Chan, W.-K., & Siu, D. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.063677 · Cited by 51
Yang, Z., Shen, W.-X., Hu, X., Zheng, D., Wu, X., Huang, Y., Chen, J., Mao, C., & Tang, J.-L. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-52 · Cited by 51
Kothari, N., Kim, R. D., Jorissen, R. N., Desai, J., Tie, J., Wong, H., Faragher, I. G., Jones, I. T., Day, F. L., Li, S., et al. (2014) · Acta Oncologica · doi:10.3109/0284186x.2014.990158 · Cited by 51
Kalman, L. V., Lubin, I. M., Barker, S., du Sart, D., Elles, R., Grody, W. W., Pazzagli, M., Richards, S., Schrijver, I., & Zehnbauer, B. A. (2013) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2012-0311-ra · Cited by 50
Self-citationLin, A. Y., Buckley, N. S., Lu, A.-T. T., Kouzminova, N. B., & Salpeter, S. R. (2011) · Clinical Colorectal Cancer · doi:10.3816/ccc.2011.n.009 · Cited by 49
Chen, J., Ye, Y., Sun, H., & Shi, G. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2005-9 · Cited by 48
EGFR Antibodies in Colorectal Cancer: Where Do They Belong?
Grothey, A. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.3407 · Cited by 47
Ulivi, P., Capelli, L., Valgiusti, M., Zoli, W., Scarpi, E., Chiadini, E., Rosetti, P., Bravaccini, S., Calistri, D., Saragoni, L., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-87 · Cited by 47
Carotenuto, P., Roma, C., Rachiglio, A. M., Tatangelo, F., Pinto, C., Ciardiello, F., Nappi, O., Iaffaioli, V. R., Botti, G., & Normanno, N. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.86 · Cited by 46
Wang, Z., Gao, Q., & Fang, J. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1886-y · Cited by 44
Wu, S., Gan, Y., Wang, X., Liu, J., Li, M., & Tang, Y. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1400-x · Cited by 44
Cejas, P., López-Gómez, M., Aguayo, C., Madero, R., Moreno‐Rubio, J., de Castro, J., Belda-Iniesta, C., Barriuso, J., Garcia, V. M., Diaz, E., et al. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912799095162 · Cited by 44
Lin, J. S., Webber, E. M., Senger, C. A., Holmes, R. S., & Whitlock, E. P. (2011) · PubMed · Cited by 41
Loupakis, F., Cremolini, C., Salvatore, L., Schirripa, M., Lonardi, S., Vaccaro, V., Cuppone, F., Giannarelli, D., Zagonel, V., Cognetti, F., et al. (2011) · Cancer · doi:10.1002/cncr.26460 · Cited by 41
Kristensen, L. S., Daugaard, I., Christensen, M., Hamilton-Dutoit, S. J., Hager, H., & Hansen, L. L. (2010) · Human Mutation · doi:10.1002/humu.21358 · Cited by 38
Cui, D., Cao, D., Yang, Y., Qiu, M., Huang, Y., & Cheng, Y. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-2974-8 · Cited by 38
Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing
Sakai, K., Tsurutani, J., Yamanaka, T., Yoneshige, A., Ito, A., Togashi, Y., Velasco, M. A. D., Terashima, M., Fujita, Y., Tomida, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121891 · Cited by 37
Chang, Y., Yeh, K., Hsu, N. C.-H., Lin, S., Chang, T., & Chang, J. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.10.007 · Cited by 37
Ku, G. Y., Haaland, B. A., & Lopes, G. D. L., Jr. (2012) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-1898-7 · Cited by 37
Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer
Pinto, P., Rocha, P., Veiga, I., Guedes, J. G., Pinheiro, M., Peixoto, A., Pinto, C., Fragoso, M., Sanches, E., Araújo, A., et al. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.003 · Cited by 37
Price, T. J., Hardingham, J. E., Lee, C. K., Townsend, A. R., Wrin, J., Wilson, K., Weickhardt, A. J., Simes, R. J., Murone, C., & Tebbutt, N. C. (2013) · Cancer Medicine · doi:10.1002/cam4.75 · Cited by 35
Nardon, E., Glavač, D., Benhattar, J., Groenen, P. J. T. A., Höfler, G., Höfler, H., Jung, A., Keller, G., Kirchner, T., Lessi, F., et al. (2010) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e3181db67af · Cited by 35
Lin, M. S., Huang, J. X., Chen, W., Zhang, B. F., Fang, J., Zhou, Q., Hu, Y., & Heng Jun, G. A. O. (2011) · Oncology Letters · doi:10.3892/ol.2011.414 · Cited by 34
Zhou, S., Huang, Y., Wei, Y., Jiang, Z.-M., Zhang, Y.-D., Yang, Q., & Xie, D.-R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050925 · Cited by 31
Modest, D. P., Brodowicz, T., Stintzing, S., Jung, A., Neumann, J. H. L., Laubender, R. P., Ocvirk, J., Kurteva, G. P., Pápai, Z., Knittelfelder, R., et al. (2012) · Oncology · doi:10.1159/000339534 · Cited by 30
Etienne-Grimaldi, M.-C., Mahamat, A., Chazal, M., Laurent‐Puig, P., Olschwang, S., Gaub, M.-P., Formento, J. L., Formento, P., Sudaka, A., Boige, V., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.213 · Cited by 28
Ibrahim, E. M., Zekri, J., & Sadiq, B. M. B. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-010-0927-4 · Cited by 28
Shen, Y. L., Yang, J., Xu, Z., 顾东英, & Chen, J. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i21.2712 · Cited by 24
Ross, J. S. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0478-ra · Cited by 23
Laosinchai-Wolf, W., Ye, F., Tran, V. D., Yang, Z., White, R., Bloom, K., Choppa, P., & Labourier, E. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.081539 · Cited by 23
Zhang, L., Ma, L., & Zhou, Q. (2011) · International Journal of Colorectal Disease · doi:10.1007/s00384-011-1197-5 · Cited by 20
Ibrahim, E. M., & Abouelkhair, K. M. (2011) · Medical Oncology · doi:10.1007/s12032-010-9760-4 · Cited by 19
KRAS discordance between primary and recurrent tumors after radical resection of colorectal cancers
Lee, K. H., Kim, J. S., Lee, C. S., & Kim, J. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23936 · Cited by 19
Cavallini, A., Valentini, A. M., Lippolis, C., Campanella, D., Guerra, V., & Caruso, M. L. (2010) · PubMed · Cited by 15
Kristensen, L. S., Kjeldsen, T. E., Hager, H., & Hansen, L. L. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-548 · Cited by 14
Buxhofer‐Ausch, V., Ausch, C., Zeillinger, R., Oberkanins, C., Dandachi, N., Reiner‐Concin, A., & Kriegshäuser, G. (2013) · Disease Markers · doi:10.1155/2013/740659 · Cited by 8
Chow, L., Lin, P., Chang, J. S.-M., Chu, P., Lee, P.-Y., Chen, S. L., Cheng, Y., Lee, J., Chang, J., & Liu, T. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20673 · Cited by 7
Cited by
Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.9901 · Cited by 2,079
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0388-cp · Cited by 936
Self-citationLindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
Self-citationPathways of Colorectal Carcinogenesis
Nguyen, L. H., Goel, A., & Chung, D. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.059 · Cited by 606
Tsilimigras, D. I., Brodt, P., Clavien, P.-A., Muschel, R. J., D’Angelica, M. I., Endo, I., Parks, R. W., Doyle, M., de Santibañes, E., & Pawlik, T. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00261-6 · Cited by 556
Metadata
- Authors
- Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., Kopetz, S. E., Lieu, C., Lindor, N. M., Minsky, B. D., Monzon, F. A., Sargent, D. J., Singh, V. M., Willis, J., Clark, J., Colasacco, C., Rumble, R. B., Temple-Smolkin, R., Ventura, C. B., & Nowak, J. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2017-05-01
- Volume
- 35
- Issue
- 13
- Pages
- 1453-1486
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2589836162
- Cited by
- 360
- References
- 135
- FWCI
- 18.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.